Home/Filings/4/0001209191-10-010135
4//SEC Filing

Parnell Sally A. 4

Accession 0001209191-10-010135

CIK 0001129623other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 6:58 PM ET

Size

12.0 KB

Accession

0001209191-10-010135

Insider Transaction Report

Form 4
Period: 2010-02-12
Parnell Sally A.
SVP, Clinical Affairs
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.001 per share

    2010-02-12$15.56/sh+2,327$36,2082,327 total
  • Exercise/Conversion

    Restricted Stock Units

    2010-02-122,3276,984 total
    Exercise: $0.00From: 2010-02-13Common Stock (2,327 underlying)
  • Tax Payment

    Common Stock, par value $0.001 per share

    2010-02-12$15.56/sh760$11,8261,567 total
  • Sale

    Common Stock, par value $0.001 per share

    2010-02-16$15.64/sh1,567$24,5080 total
Holdings
  • Restricted Stock Units

    Exercise: $0.00From: 2011-01-04Common Stock (6,321 underlying)
    6,321
Footnotes (3)
  • [F1]Sales were pursuant to a Rule 10b5-1 plan established by the Reporting Person on November 17, 2009.
  • [F2]The restricted stock units vest in four equal annual installments beginning on the Exercisable Date. Vested shares will be delivered to the reporting person on each vesting date.
  • [F3]N/A - restricted stock unit

Issuer

ODYSSEY HEALTHCARE INC

CIK 0001129623

Entity typeother

Related Parties

1
  • filerCIK 0001454187

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 6:58 PM ET
Size
12.0 KB